Pfizer Inc was planning to make a sweetened bid for AstraZeneca PLC on Sunday, the Wall Street Journal reported on Sunday, citing people familiar with the matter. Pfizer, which has already been rebuffed more than once by AstraZeneca, first approached it late last year about a trans-Atlantic tie-up that would rank as one of the healthcare industry's biggest ever, WSJ reported.
AstraZeneca PLC (AstraZeneca) is a global biopharmaceutical company. Shares of AZN fell by 0.3% or $-0.24/share to $80.28. In the past year, the shares have traded as low as $46.87 and as high as $82.68. On average, 4206660 shares of AZN exchange hands on a given day and today's volume is recorded at 8986704.
Pfizer Inc. (Pfizer) is a research-based, global biopharmaceutical company. Shares of PFE traded higher by 0.21% or $0.06/share to $29.12. In the past year, the shares have traded as low as $27.12 and as high as $32.96. On average, 30588100 shares of PFE exchange hands on a given day and today's volume is recorded at 35704300.
Source
